Are EM stocks flashing a 'sell' signal? Are EM stocks flashing a 'sell' signal? Are EM stocks flashing a 'sell' signal?

Are EM stocks flashing a 'sell' signal?

Equities 3 minutes to read
Michael McKenna

Head of Editorial Content, Saxo Bank

Summary:  The iShares MSCI Emerging Markets Index Fund is now below crucial support at 41.50 as the China-US trade war rages on.

The US-China trade war is reconfiguring the global supply chain, depressing risk sentiment, and providing a significant headwind to emerging market equities. The latest Asian export data indicate that an overall regional slowdown is indeed in place, and it could be growing worse. Investors are now looking to Beijing for new stimulus measures, but it remains unclear just how far Chinese authorities are willing to go.

The longtime, unofficial USDNCH cap at 7.00 is one element that markets are now watching for signs of breakdown. China’s May 15 decision to apply an RRR discount to small- and medium-sized received only the most tepid response.

Collateral damage in EM

Risk aversion and Chinese weakness point to a likely decline in emerging market equity prices. On Monday, Saxo Bank Head of Equity Strategy Peter Garnry outlined his thoughts on how the “new Cold War” developing between the US and China represents a sell signal for EM stocks. Garnry states:

Emerging markets have declined almost 10% in just four weeks and we expect this trend to grow much worse given the current trajectory of the US-China trade headlines. Our tactical asset allocation view is to be underweight emerging markets. It also seems that the market is the least complacent on direct and indirect exposures to China, so the best way to express negative views on trade is via emerging market equities, KRW, JPY, oil, Australian equities and bunds.

A technical view

We are looking at the EM equities complex via the iShares MSCI Emerging Markets Index (EEM:arcx), where this month has seen investors offloading investments from EM at the fastest rate since last year’s Turkish and Argentinian crises. 

“The iShares MSCI Emerging Markets Index Fund has fallen by 12% since its April peak compared to under 6% for the S&P 500,” says Saxo technical analyst Kim Cramer Larsson

“Investors are moving out of higher-risk assets”.

With EEM now below the previous support area at 41.50, Larsson now sees the ETF closing the breakaway gap from January. “This means no strong support before the December 2018 low around 38,” he adds.

The relative Strength Index is in bearish territory with minor divergence, indicating that the selling pressure is weakening.
EEM: arcx
iShares MSCI Emerging Markets Index Fund (EEM:arcx, source: Saxo Bank)

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.